162 related articles for article (PubMed ID: 1350235)
1. The hemodynamic effects of adrenergic blocking agents.
Lund-Johansen P
Cleve Clin J Med; 1992; 59(2):193-200. PubMed ID: 1350235
[TBL] [Abstract][Full Text] [Related]
2. Acute and chronic hemodynamic effects of drugs with different actions on adrenergic receptors: a comparison between alpha blockers and different types of beta blockers with and without vasodilating effect.
Lund-Johansen P; Omvik P
Cardiovasc Drugs Ther; 1991 Jun; 5(3):605-15. PubMed ID: 1678963
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
Lund-Johansen P
Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic and physiologic considerations of adrenoceptor blockade.
Frohlich ED; Dunn FG; Messerli FH
Am J Med; 1983 Oct; 75(4A):9-14. PubMed ID: 6139019
[TBL] [Abstract][Full Text] [Related]
5. The influence of vasodilating beta-blockers on cardiac function and vascular resistance in essential hypertension.
Lund-Johansen P
Clin Nephrol; 1992; 38 Suppl 1():S78-86. PubMed ID: 1363538
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.
Mehta J; Cohn JN
Circulation; 1977 Feb; 55(2):370-5. PubMed ID: 12880
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic changes after acute and long-term combined alpha--beta-adrenoceptor blockade with labetalol as compared with beta-receptor blockade.
Koch G
J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S30-41. PubMed ID: 6169958
[TBL] [Abstract][Full Text] [Related]
8. Haemodynamic effects of beta-receptor blockade during acute administration and chronic treatment.
Jensen HA
Acta Med Scand Suppl; 1982; 665():79-81. PubMed ID: 6130678
[TBL] [Abstract][Full Text] [Related]
9. Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
Roberts DH; Tsao Y; Grimmer SF; Winstanley PA; Orme ML; Breckenridge AM
Br J Clin Pharmacol; 1987 Aug; 24(2):163-72. PubMed ID: 2887190
[TBL] [Abstract][Full Text] [Related]
10. Haemodynamic consequences of intrinsic sympathomimetic activity and cardioselectivity in beta-blocker therapy for hypertension.
Man in 't Veld AJ; Schalekamp MA
Eur Heart J; 1983 Jul; 4 Suppl D():31-41. PubMed ID: 6137381
[TBL] [Abstract][Full Text] [Related]
11. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Prichard BN
Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
[TBL] [Abstract][Full Text] [Related]
12. Differential hemodynamic effects of beta-adrenoceptor blockers, Ca antagonists and combined alpha-beta-receptor blockade in ischemic heart disease.
Koch G
Acta Med Scand; 1986; 219(1):17-22. PubMed ID: 2869648
[TBL] [Abstract][Full Text] [Related]
13. Acute effects of combined alpha/beta-adrenoceptor blockade v combined beta-receptor and slow channel calcium blockade in ischemic heart disease complicated by hypertension. Hemodynamic and adrenergic responses.
Koch G; Fransson L
Am J Hypertens; 1991 Aug; 4(8):709-13. PubMed ID: 1681821
[TBL] [Abstract][Full Text] [Related]
14. Hypotensive mechanisms of beta blockers.
Conway J
Eur Heart J; 1983 Jul; 4 Suppl D():43-51. PubMed ID: 6137382
[TBL] [Abstract][Full Text] [Related]
15. Properties of labetalol, a combined alpha- and beta-blocking agent, relevant to the treatment of myocardial ischemia.
Frishman WH
Cardiovasc Drugs Ther; 1988 Sep; 2(3):343-53. PubMed ID: 2908732
[TBL] [Abstract][Full Text] [Related]
16. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
Man in't Veld AJ; Schalekamp MA
Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
[TBL] [Abstract][Full Text] [Related]
17. Rationale for combined alpha-beta-adrenoceptor blockade: haemodynamic considerations.
Koch G
Acta Med Scand Suppl; 1982; 665():87-92. PubMed ID: 6130680
[TBL] [Abstract][Full Text] [Related]
18. Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure.
Lund-Johansen P; Omvik P; Nordrehaug JE; White W
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S27-34. PubMed ID: 1378146
[TBL] [Abstract][Full Text] [Related]
19. Effect of beta blockers on vascular resistance in systemic hypertension.
Man in 't Veld AJ
Am J Cardiol; 1987 May; 59(13):21F-25F. PubMed ID: 2883873
[TBL] [Abstract][Full Text] [Related]
20. Haemodynamic effects of combined alpha- and beta-adrenoreceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise.
Koch G
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):725-8. PubMed ID: 10950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
